Portfolio company
Gyros AB
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
The company develops automated microfluidic immunoassay platforms and peptide synthesisers for biopharmaceutical manufacturers and contract research organisations to accelerate drug development.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Fluidic Sciences Ltd
This company manufactures microfluidic instruments and consumables for protein interaction analysis and single-cell screening to assist biopharmaceutical researchers with drug discovery.
Fida Biosystems
This company develops biophysical analysis platforms for characterising proteins and nanoparticles, serving researchers, biotechnology firms, and pharmaceutical manufacturers to accelerate drug development.
Personal Chemistry AB
This company develops automated microwave synthesis systems and purification platforms for medicinal and combinatorial chemistry research in pharmaceutical and biotechnology industries.
PeptiSystems
The company manufactures automated continuous-flow synthesizers for biopharmaceutical and biotech firms to produce peptide and oligonucleotide therapeutics from development to large-scale manufacturing.
Amide
The company manufactures complex synthetic peptides using robotic automation and fast flow synthesis technology for biopharmaceutical researchers and drug development customers.
FOx Biosystems
This company develops fibre-optic biosensors and analytical instruments for life science and pharmacological research labs to perform real-time, label-free biomolecular interaction analysis.
Finnadvance
This company develops microfluidic organ-on-chip platforms for pharmaceutical and academic researchers to perform drug testing and mimic human organ functions.
Proteomics
This company develops automated benchtop instruments for multiplexed protein analysis to assist researchers in the biotechnology and pharmaceutical industries.
